Cargando…
Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682866/ https://www.ncbi.nlm.nih.gov/pubmed/37806673 http://dx.doi.org/10.1002/ehf2.14549 |
| _version_ | 1785151069309894656 |
|---|---|
| author | Hammer, Andreas Niessner, Alexander Sulzgruber, Patrick |
| author_facet | Hammer, Andreas Niessner, Alexander Sulzgruber, Patrick |
| author_sort | Hammer, Andreas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10682866 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106828662023-11-30 Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction? Hammer, Andreas Niessner, Alexander Sulzgruber, Patrick ESC Heart Fail Letter to the Editor John Wiley and Sons Inc. 2023-10-08 /pmc/articles/PMC10682866/ /pubmed/37806673 http://dx.doi.org/10.1002/ehf2.14549 Text en © 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letter to the Editor Hammer, Andreas Niessner, Alexander Sulzgruber, Patrick Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction? |
| title | Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction? |
| title_full | Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction? |
| title_fullStr | Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction? |
| title_full_unstemmed | Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction? |
| title_short | Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction? |
| title_sort | vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682866/ https://www.ncbi.nlm.nih.gov/pubmed/37806673 http://dx.doi.org/10.1002/ehf2.14549 |
| work_keys_str_mv | AT hammerandreas vericiguatafifthcornerstoneinthetreatmentofheartfailurewithreducedejectionfraction AT niessneralexander vericiguatafifthcornerstoneinthetreatmentofheartfailurewithreducedejectionfraction AT sulzgruberpatrick vericiguatafifthcornerstoneinthetreatmentofheartfailurewithreducedejectionfraction |